|Salary:||£37,050 to £45,732 per annum|
|Placed On:||19th January 2023|
|Closes:||5th February 2023|
Location: Sutton (Greater London)
Contract Length: 2 years
Salary: Subject to comparable skills and experience. Future progression is based on annual performance review.
This role is eligible for ICR Sponsorship. Support will be provided for costs associated with Visa application. If you are considering relocating to the UK, further information can be found here.
Duration of Contract: Fixed Term for 2 years
Hours per week: 35 hours per week (Full Time)
The appointed Quality Assurance and Pharmacovigilance Officer will work as a member of the ICR-CTSU/DDU Quality Assurance Review Team to provide continued quality oversight of our trials activity and to ensure on-going compliance with applicable regulatory standards. The post holder will coordinate and conduct audits of clinical trial documentation and procedures and be responsible for ensuring procedures are fit for purpose and commensurate with level of risk. They will also be responsible for quality control of pharmacovigilance activities and be a pro-active member of the ICR-CTSU/DDU pharmacovigilance working group. The post holder will provide quality assurance and pharmacovigilance advice and support to colleagues within ICR-CTSU and DDU and represent ICR-CTSU and DDU at relevant meetings within the wider ICR and Royal Marsden (RM) institutions and nationally, as required.
The successful candidate must have a proven track record conducting audits and developing Standard Operating Procedures and have working knowledge of the Medicines for Human Use Clinical Trial Regulations. Experience and working knowledge of pharmacovigilance reporting is preferable. Candidates must demonstrate effective verbal and written communication and have excellent organisational skills.
The ICR's Clinical Trials and Statistics Unit (ICR-CTSU) and the Drug Development Unit (DDU) are seeking a Quality Assurance and Pharmacovigilance Officer to join their team at ICR’s Sutton site in Surrey. The DDU specialises in first-in-human trials and provides a pathway from pre clinical drug discovery through to proof of principle phase I trials and tumour specific evaluation of novel agents. ICR-CTSU runs a diverse portfolio of national and international phase III multicentre randomised controlled trials, and phase II trials of targeted treatments with a focus on breast, urological and head and neck cancer treatments. The post-holder will work across both teams, with dedicated time in each department.
We encourage all applicants to access the job pack attached for more detailed information regarding this role. Informal enquiries can be made by emailing firstname.lastname@example.org.
About The Institute of Cancer Research
Why work for us?
As a member of staff, you'll have exclusive access to a range of staff benefits.
The ICR is committed to supporting overseas applicants applying for roles, please click here to find out further information.
The Institute of Cancer Research, London, is one of the world's most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. Further information about working at the ICR can be found here.
We look forward to receiving applications from all candidates, wherever in the world they are currently based. We will select those who display the potential to become, or to support, the world leading cancer researchers of the future based on their application and performance at interview. However, we particularly welcome British applicants from black and ethnic minority backgrounds, as they are under-represented within the ICR and nationwide in STEM roles.
Type / Role: